-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOMEA FUSION ANNOUNCES COMPLETION OF ENROLLMENT IN COVALENT-211 PHASE II TRIAL OF ICOVAMENIB IN INSULIN-DEFICIENT TYPE 2 DIABETES

Reuters·08/24/2026 11:00:01

Please log in to view news